The dosimetric leaf gap (DLG) is a beam configuration parameter used in the Varian Eclipse treatment planning system, to model the effects of rounded MLC leaf ends.
tic (SABR, also known as SBRT) fractionation schedule. Four test treatments were planned using a VMAT technique, to deliver a prescription of 24 Gy in 3 fractions to four different spine SABR treatment sites. Measurements of the doses delivered by these treatments were acquired using an ionization chamber and radiographic film.
These measurements were compared with the doses calculated by the treatment planning system using a range of DLG values, including a DLG identified using the conventional sliding-slit method (1.1 mm). An optimal DLG value was identified, as the value that produced the closest agreement between the planned and measured doses (1.9 mm). The accuracy of the dose calculations produced using the optimized DLG value was verified using additional radiochromic film measurements in a heterogeneous phantom. This study provided a specific initial DLG (1.9 mm) as well as a film-based optimization method, which may be used by radiotherapy centers when attempting to commission or improve an FFF VMAT-based SABR treatment programme. 
| INTRODUCTION
Stereotactic ablative radiosurgery (SABR, also known as stereotactic body radiotherapy or SBRT) has been shown to be effective for treating tumors in and around the vertebra. 1, 2 These "spine SABR"
treatments require the use of a small number of treatment fractions (typically 1-4) to deliver a relatively high dose of radiation (typically 12-27 Gy). 3 In order to minimize the time taken to deliver these high-dose fractions, especially for patients who may be suffering pain and discomfort due to vertebral metastases, treatments can be delivered using high dose rate modes. Dose rates of up to 2200 MU/min can be achieved by using flattening filter free (FFF) Some of these studies have suggested that the DLG values that are required to accurately calculate dose for FFF modalities are especially different from the DLG values that are obtained using the sliding slit method. 14, 16 It is therefore important to specifically evaluate and optimize the DLG that is used when calculating dose for hypofractionated SABR treatments that use FFF VMAT beams.
This study therefore demonstrates the use of radiochromic film measurements to investigate the optimal DLG for use when treating spine SABR cases using a VMAT technique, with an FFF beam, in order to provide a specific initial DLG as well as a film-based optimization method, which may be used by radiotherapy centers when attempting to commission or improve an FFF VMAT-based SABR treatment programme.
| MATERIALS AND METHODS

2.A | Test treatment plans
The prescription used for the clinical test spine SABR treatment plans was 24 Gy, to be delivered in 3 fractions of 8 Gy. This prescription was selected with reference to literature 16 The DLG value was then iteratively altered, and each Spine SABR verification plan was calculated and compared to the measured dose distribution. This optimization process continued until the optimal DLG value was identified as the value that resulted in the best overall agreement between calculated and measured dose, for the four test plans.
2.C | DLG verification: Heterogeneous phantom
The suitability of the optimized DLG value was evaluated in an inhomogeneous phantom, the IMRT Thorax phantom (CIRS Inc, Norfolk, USA), using a fine (1 mm) dose calculation grid resolution. Only two DLG values were used when calculating the Spine SABR plans on the IMRT Thorax phantom -the initial 1.1 mm and the optimal 1.9 mm value. As these measurements in the transverse plane were used to evaluate the sparing of the spinal cord region as well as the accurate treatment of the planned high-dose (vertebral) region, both arcs from each treatment were delivered to each piece of film. This represents a single fraction treatment dose.
| RESULTS
3.A | DLG optimization: Homogeneous phantom
The DLG value for the 6 MV FFF beam with Millenium-120 MLC was found to be 1.1 mm using the sliding slit method, as shown in Fig. 1 .
Using the DLG value identified using the sliding-slit method Table 2 summarizes the gamma agreement results for each of the four test cases delivered to the thorax phantom. Figure 4 shows profiles comparing dose plane from treatment plan and film measurement in CIRS thorax phantom.
3.B | DLG verification: Heterogeneous phantom
F I G . 1. DLG measurement using sliding-slit method. A DLG of 1.1 mm was obtained by extrapolating the results obtained at different sliding slit widths, to identify the theoretical slit width that would produce a measurement of zero dose. Table 2 confirm that use of the DLG obtained through an optimization process, using VMAT spine SABR test treatment plans (1.9 mm), results in treatment plans that are substantially more dosimetrically accurate than use of the DLG obtained from the conventional sliding-slit measurement (1.1 mm).
The Eclipse AAA beam model used in this study was commissioned using data for field sizes ranging from 3 9 3 cm 2 to 40 9 40 cm 2 . 10 Although data for smaller field sizes is usually measured during linac commissioning, it is not required for commissioning of the beam model within Eclipse. 12 The DLG is used in the Varian Eclipse treatment planning system as an approximation factor to reduce the dosimetric calculation uncertainty arising from the use of a simple MLC model with straight leaf ends. Conventionally, the DLG is measured using vendor-supplied DICOM plans that produce a sliding-slit with 13 control points, where the MLC leaves move at the same speed, in one direction, with a constant dose rate. 10 This broadly approximates an IMRT delivery, where the MLC leaves move in the same direction, from one side of the field to the other, albeit at different speeds.
By contrast, VMAT treatment deliveries are much more complex.
Each VMAT arc typically uses 178 controls points, with MLC leaves undergoing frequent changes in direction. Adjacent MLC leaves may move in opposite directions to each other and at different speeds.
The dose rate is also modulated and defined for each control point.
A single point measurement using the sliding slit method does not replicate the complex MLC movements such as those in a VMAT treatment for a spine SABR case.
It is therefore unsurprising that determination of the appropriate DLG value for clinical use in planning VMAT treatments should require the use of more complex plans than the sliding-slit, evaluated using more sophisticated measurements than a point dose.
T A B L E 2 Gamma agreement indices (percentage of points passing a gamma evaluation using 3%, 1.5 mm criteria) resulting from comparing the dose measured using film in a transverse plane through the heterogeneous (thorax) phantom against the dose calculated in the same plane using the treatment planning system with the sliding-slit-based DLG (1.1 mm) and the optimization-based DLG (1.9 mm). Optimization of the DLG for VMAT treatments should involve the use of treatment plans that are representative of intended clinical use of the beam model, with measurements completed using accurate, high-resolution two-dimensional dosimeters. 9, 11, 13, 14 In this study, radiochromic film was shown to produce results that were sufficiently sensitive to DLG variation for use in DLG optimization, although verification using a second dosimeter (such as an ionization chamber) may be advisable (see Fig. 3 ). The radiochromic film used in this study also provided accurate, high-resolution measurements that allowed the suitability of the optimized DLG value to be verified, when dose was calculated at a high resolution and the test treatments were delivered to a heterogeneous phantom (see Fig. 4 ). Estimated measurement uncertainties affecting the use of radiochromic film for radiotherapy dosimetry range from 0.55% 21 to 4%. 22 It is therefore important to independently evaluate uncertainties when commissioning any radiochromic film dosimetry system that is used to optimize beam configuration values, such as the DLG. The results shown in Fig. 3 confirm the importance of optimizing the DLG using a range of clinically likely test treatments. For this study, the test treatment volumes were thoracic and lumbar vertebral bodies, with and without left and right pedicles, and the corresponding treatments were designed with a range of different field sizes and collimator angles. Figure 3 shows that the particular values of the DLG that gave the closest agreement between the planned and measured doses differed between plans and between measurement techniques. We have adopted the optimal DLG of 1.9 mm for the 6FFF beam model for use in our clinic, for treatment of spine SABR cases. We have not yet investigated the application of this optimal DLG to SABR planning for other anatomical sites. The identification of a DLG value that is optimal for an entire class of plans (for a specific treatment modality, used to treat a specific anatomical site) evidently requires the use of different examples of the specific anatomical site to be treated.
DLG (mm)
Case 1 Case 2 Case 3 Case 4 1.1 64.6 70.1 76.7 61.3 1.9 95.6 99.2 96.4 98.
| CONCLUSIONS
This study used an evaluation of DLG suitability for four spine SABR test treatment plans to confirm that the DLG identified using the conventional sliding-slit method does not produce clinical treatment plans that show good agreement between planned and measured doses for VMAT treatments delivered using a FFF beam.
Based on the results of this study, the following general recommendations can be made, for optimizing the DLG for use in planning spine SABR (or any other) VMAT treatments:
1. A range of clinically likely test treatments should be used when optimizing the DLG;
2. The suitability of each tested DLG value should be evaluated against measurements made using an accurate high-resolution dosimeter, such as radiochromic film; 
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